240 Humanized CD30 chimeric antigen receptor T cells with a novel 4–1BB derived spacer have improved activity and safety against CD30-positive lymphomas | Zendy

AI Assistant Blog Pricing

240 Humanized CD30 chimeric antigen receptor T cells with a novel 4–1BB derived spacer have improved activity and safety against CD30-positive lymphomas

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.